EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endothelium‐Derived Engineered Extracellular Vesicles Protect the Pulmonary Endothelial Barrier in Acute Lung Injury

Zhengyan Gu iD, Mingxue Sun, Jihao Liu, Qi Huang, Yunqin Wang, Jun Liao, Tingbin Shu, Min Tao, Guanchao Mao, Zhipeng Pei, Wenqi Meng, Xinkang Zhang und 6 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202306156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zhengyan Gu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, 200433, P. R. China. Hauptthemen laut MEDLINE: MicroRNAs, Acute Lung Injury, Extracellular Vesicles. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Shanghai Municipal Health Commission-Outstanding Youth Foundation of Public Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) is a severe respiratory disease with a high mortality rate. The integrity of the pulmonary endothelial barrier influences the development and prognosis of ALI. Therefore, it has become an important target for ALI treatment. Extracellular vesicles (EVs) are promising nanotherapeutic agents against ALI. Herein, endothelium‐derived engineered extracellular vesicles (eEVs) that deliver microRNA‐125b‐5p (miRNA‐125b) to lung tissues exerting a protective effect on endothelial barrier integrity are reported. eEVs that are modified with lung microvascular endothelial cell‐targeting peptides (LET) exhibit a prolonged retention time in lung tissues and targeted lung microvascular endothelial cells in vivo and in vitro. To improve the efficacy of the EVs, miRNA‐125b is loaded into EVs. Finally, LET‐EVs‐miRNA‐125b is constructed. The results show that compared to the EVs, miRNA‐125b, and EVs‐miRNA‐125b, LET‐EVs‐miRNA‐125b exhibit the most significant treatment efficacy in ALI. Moreover, LET‐EVs‐miRNA‐125b is found to have an important protective effect on endothelial barrier integrity by inhibiting cell apoptosis, promoting angiogenesis, and protecting intercellular junctions. Sequencing analysis reveals that LET‐EVs‐miRNA‐125b downregulates early growth response‐1 (EGR1) levels, which may be a potential mechanism of action. Taken together, these findings suggest that LET‐EVs‐miRNA‐125b can treat ALI by protecting the endothelial barrier integrity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsAcute Lung InjuryExtracellular VesiclesHumansEndothelial CellsLungEndothelium

Stichwörter der Autor:innen

EGR1acute lung injuryengineered extracellular vesiclesextracellular vesiclespulmonary endothelial barrier

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Lab of Toxicology and Pharmacology, Faculty of Naval Medicine, Naval Medical University, Shanghai, 200433, P. R. China.
  • Department of Pharmaceutical Sciences, School of Pharmacy, Naval Medical University, Shanghai, 200433, P. R. China.
  • School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110006, P. R. China.
  • School of Medicine, Shanghai University, Shanghai, 200444, P. R. China.
  • State Key Laboratory of Genetic Engineering, Institute of Genetics, Fudan University, Shanghai, 200433, P. R. China.
  • Marine Biomedical Science and Technology Innovation Platform of Lingang Special Area, Shanghai, 200433, P. R. China.

ORCID-Profile: Zhengyan Gu, Kai Xiao, Ying Lu, Qingqiang Xu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Shanghai Municipal Health Commission-Outstanding Youth Foundation of Public Health
  • National Key R&D Program of China
  • SciTech Funding by CSPFTZ Lingang Special Area Marine Biomedical Innovation Platform
  • Natural Science Foundation of Shanghai Municipality
  • National Key Research and Development Program of China

Zitieren

APA

Gu, Z., Sun, M., Liu, J., Huang, Q., Wang, Y., Liao, J., Shu, T., Tao, M., Mao, G., Pei, Z., Meng, W., Zhang, X., Wei, Y., Zhang, S., Li, S., Xiao, K., Lu, Y., & Xu, Q. (2024). Endothelium‐Derived Engineered Extracellular Vesicles Protect the Pulmonary Endothelial Barrier in Acute Lung Injury. Advanced Science. https://doi.org/10.1002/advs.202306156

Vancouver

Gu Z, Sun M, Liu J, Huang Q, Wang Y, Liao J, et al. Endothelium‐Derived Engineered Extracellular Vesicles Protect the Pulmonary Endothelial Barrier in Acute Lung Injury. Advanced Science. 2024. doi:10.1002/advs.202306156

BibTeX
@article{Gu2024,
  author = {Gu, Zhengyan and Sun, Mingxue and Liu, Jihao and Huang, Qi and Wang, Yunqin and Liao, Jun and Shu, Tingbin and Tao, Min and Mao, Guanchao and Pei, Zhipeng and Meng, Wenqi and Zhang, Xinkang and Wei, Youheng and Zhang, Shanshan and Li, Songling and Xiao, Kai and Lu, Ying and Xu, Qingqiang},
  title = {Endothelium‐Derived Engineered Extracellular Vesicles Protect the Pulmonary Endothelial Barrier in Acute Lung Injury},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202306156}
}
Kostenlos starten →